3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
4
Multiple Myeloma
2
Vaccinia
1
Transplant-Related Hematologic Malignancy
1
Recurrence
1
Prostatic Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Medulloblastoma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hodgkin Disease
1
Glioma
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Interventions
Gemcitabine
33
Cisplatin
22
pembrolizumab
21
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
12
Mitomycin
10
enfortumab vedotin
9
avelumab
9
Nivolumab
9
Cystoscopy
9
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
7
Radiotherapy
6
Immunoglobulin G
6
Docetaxel
6
Disulfides
6
atezolizumab
5
Transurethral Resection of Bladder
5
Mitozytrex
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Standard of Care
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
Granulocyte-Macrophage Colony-Stimulating Factor
×
90 days
×
Clear all
No trials found.